624 related articles for article (PubMed ID: 30052747)
1. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
Hwang AY; Dave CV; Smith SM
Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
[TBL] [Abstract][Full Text] [Related]
2. Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs.
Langman MJ; Eichler HG; Mavros P; Watson DJ; Kong SX
Int J Clin Pharmacol Ther; 2004 May; 42(5):260-6. PubMed ID: 15176648
[TBL] [Abstract][Full Text] [Related]
3. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
[TBL] [Abstract][Full Text] [Related]
4. Identifying and managing factors that interfere with or worsen blood pressure control.
Basile JN; Bloch MJ
Postgrad Med; 2010 Mar; 122(2):35-48. PubMed ID: 20203454
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension.
Aljadhey H; Tu W; Hansen RA; Blalock SJ; Brater DC; Murray MD
BMC Cardiovasc Disord; 2012 Oct; 12():93. PubMed ID: 23092442
[TBL] [Abstract][Full Text] [Related]
6. Trends in Antihypertensive Medication Use Among US Patients With Resistant Hypertension, 2008 to 2014.
Hwang AY; Dave C; Smith SM
Hypertension; 2016 Dec; 68(6):1349-1354. PubMed ID: 27777360
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication.
Shimbo D; Barrett Bowling C; Levitan EB; Deng L; Sim JJ; Huang L; Reynolds K; Muntner P
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):222-9. PubMed ID: 27166208
[TBL] [Abstract][Full Text] [Related]
8. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.
Daugherty SL; Powers JD; Magid DJ; Masoudi FA; Margolis KL; O'Connor PJ; Schmittdiel JA; Ho PM
Hypertension; 2012 Aug; 60(2):303-9. PubMed ID: 22733464
[TBL] [Abstract][Full Text] [Related]
9. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
[TBL] [Abstract][Full Text] [Related]
10. Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?
Hedna K; Hakkarainen KM; Gyllensten H; Jönsson AK; Andersson Sundell K; Petzold M; Hägg S
PLoS One; 2015; 10(9):e0137451. PubMed ID: 26359861
[TBL] [Abstract][Full Text] [Related]
11. Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension.
Bromfield SG; Ngameni CA; Colantonio LD; Bowling CB; Shimbo D; Reynolds K; Safford MM; Banach M; Toth PP; Muntner P
Hypertension; 2017 Aug; 70(2):259-266. PubMed ID: 28652459
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
13. A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures.
Vigen R; Shetterly S; Magid DJ; O'Connor PJ; Margolis KL; Schmittdiel J; Ho PM
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):276-82. PubMed ID: 22576846
[TBL] [Abstract][Full Text] [Related]
14. Resistant hypertension: an overview of evaluation and treatment.
Sarafidis PA; Bakris GL
J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
[TBL] [Abstract][Full Text] [Related]
16. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
[TBL] [Abstract][Full Text] [Related]
17. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study.
Fournier JP; Sommet A; Bourrel R; Oustric S; Pathak A; Lapeyre-Mestre M; Montastruc JL
Eur J Clin Pharmacol; 2012 Nov; 68(11):1533-40. PubMed ID: 22527348
[TBL] [Abstract][Full Text] [Related]
19. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.
St Peter WL; Sozio SM; Shafi T; Ephraim PL; Luly J; McDermott A; Bandeen-Roche K; Meyer KB; Crews DC; Scialla JJ; Miskulin DC; Tangri N; Jaar BG; Michels WM; Wu AW; Boulware LE;
BMC Nephrol; 2013 Nov; 14():249. PubMed ID: 24219348
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
